Comparative Pharmacology
Head-to-head clinical analysis: VALNAC versus VORAXAZE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: VALNAC versus VORAXAZE.
VALNAC vs VORAXAZE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Valproate semisodium (valproic acid derivative) increases GABA levels in the brain by inhibiting GABA transaminase and succinic semialdehyde dehydrogenase, and modulates voltage-gated sodium channels and T-type calcium channels. The combination (valproate semisodium) dissociates in the gastrointestinal tract to valproic acid and sodium valproate, providing rapid absorption and sustained release.
Glucarpidase is a recombinant bacterial enzyme that hydrolyzes the glutamate residue from methotrexate and its metabolites, converting them to nontoxic metabolites.
Adults: 650 mg orally twice daily, with a maximum of 1300 mg per day.
2000 units intravenously over 5 minutes as a single dose.
None Documented
None Documented
3-5 hours (healthy adults). In severe renal impairment (CrCl <30 mL/min), half-life extends to 12-24 hours, increasing risk of accumulation and toxicity.
Terminal elimination half-life is approximately 10 hours (range 6-16 hours) in patients with normal renal function. In patients with methotrexate-induced renal impairment, half-life may be prolonged up to 20-30 hours. Clinical context: the half-life determines the timing of repeat dosing or monitoring; a single dose typically reduces methotrexate levels by >97% within 15 minutes.
Primarily renal (90% unchanged drug), with 10% biliary-fecal. In renal impairment, half-life prolongs significantly, requiring dose adjustment.
Voraxaze (glucarpidase) is a recombinant enzyme that rapidly cleaves circulating methotrexate into inactive metabolites (DAMPA and glutamate). It is not significantly renally or hepatically excreted; rather, it is a high-molecular-weight protein that is catabolized via proteolysis. The majority of the administered dose is metabolized and eliminated as smaller peptides and amino acids. Less than 1% is excreted unchanged in urine.
Category C
Category C
Antidote
Antidote